Skip to main content
Top

2009 | OriginalPaper | Hoofdstuk

22 Levertransplantatie

Auteurs : Dr. B. van Hoek, Prof.dr. H.J. Verkade, Prof.dr. R.J. Porte

Gepubliceerd in: Leverziekten

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

In 1963 verrichtte Thomas Starzl in Denver de eerste levertransplantatie bij de mens. In 1966 werden in Nederland de eerste twee (auxiliaire, zie par. 22.3.6) levertransplantaties verricht in Leiden en Arnhem, in 1968 startte Cambridge. Helaas resulteerden de eerste levertransplantaties niet in langetermijnoverleving als gevolg van niet-optimale operatietechniek, matige immuunsuppressie en onbekendheid met complicaties.
Literatuur
1.
go back to reference Killenberg P, Clavien P-A. Medical care of the liver transplant patient: Total pre-, intra- and postoperative management. 3rd ed. London: Wiley-Blackwell, 2006.CrossRef Killenberg P, Clavien P-A. Medical care of the liver transplant patient: Total pre-, intra- and postoperative management. 3rd ed. London: Wiley-Blackwell, 2006.CrossRef
2.
go back to reference Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007;45(3):797-805.PubMedCrossRef Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007;45(3):797-805.PubMedCrossRef
3.
go back to reference Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. AJT 2006;6(4):783-90.CrossRef Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. AJT 2006;6(4):783-90.CrossRef
4.
go back to reference Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8(2):419-25.PubMedCrossRef Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8(2):419-25.PubMedCrossRef
5.
go back to reference Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007;11(2):249-63.PubMedCrossRef Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007;11(2):249-63.PubMedCrossRef
6.
go back to reference Londoño MC, Cárdenas A, Guevara M, Quintó L, De Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007;56(9):1283-90.PubMedCentralPubMedCrossRef Londoño MC, Cárdenas A, Guevara M, Quintó L, De Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007;56(9):1283-90.PubMedCentralPubMedCrossRef
7.
go back to reference Neuberger J, Gimson A, Davies M, Akyol M, O’Grady J, Burroughs A, Hudson M. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57:252-7.PubMedCrossRef Neuberger J, Gimson A, Davies M, Akyol M, O’Grady J, Burroughs A, Hudson M. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57:252-7.PubMedCrossRef
8.
go back to reference Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-9.PubMedCrossRef Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-9.PubMedCrossRef
9.
go back to reference Walzer N, Kulik LM. Hepatocellular carcinoma: latest developments. Curr Opin Gastroenterol 2008;24(3):312-9.PubMedCrossRef Walzer N, Kulik LM. Hepatocellular carcinoma: latest developments. Curr Opin Gastroenterol 2008;24(3):312-9.PubMedCrossRef
10.
go back to reference Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 2008;24(3):384-8.PubMedCrossRef Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 2008;24(3):384-8.PubMedCrossRef
11.
go back to reference Auzinger G, Wendon J. Intensive care management of acute liver failure. Curr Opin Crit Care 2008;14(2):179-88.PubMedCrossRef Auzinger G, Wendon J. Intensive care management of acute liver failure. Curr Opin Crit Care 2008;14(2):179-88.PubMedCrossRef
13.
go back to reference Blei AT. Brain edema in acute liver failure. Crit Care Clin 2008;24(1):99-114, ix. Blei AT. Brain edema in acute liver failure. Crit Care Clin 2008;24(1):99-114, ix.
14.
go back to reference Cholongitas E, O’Beirne J, Betrossian A, Senzolo M, Shaw S, Patch D, Burroughs AK. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14(1):121-2.PubMedCrossRef Cholongitas E, O’Beirne J, Betrossian A, Senzolo M, Shaw S, Patch D, Burroughs AK. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14(1):121-2.PubMedCrossRef
15.
go back to reference Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11(9):1073-9.PubMedCrossRef Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11(9):1073-9.PubMedCrossRef
16.
go back to reference Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl 2007;13(6):814-21.PubMedCrossRef Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl 2007;13(6):814-21.PubMedCrossRef
17.
go back to reference Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in children: 37-year experience and revised King’s score for liver transplantation. Liver Transpl 2005;11(4):441-8.PubMedCrossRef Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in children: 37-year experience and revised King’s score for liver transplantation. Liver Transpl 2005;11(4):441-8.PubMedCrossRef
18.
go back to reference Petrasek J, Jirsa M, Sperl J, Kozak L, Taimr P, Spicak J, Filip K, Trunecka P. Revised King’s College score for liver transplantation in adult patients with Wilson’s disease. Liver Transpl 2007;13(1):55-61.PubMedCrossRef Petrasek J, Jirsa M, Sperl J, Kozak L, Taimr P, Spicak J, Filip K, Trunecka P. Revised King’s College score for liver transplantation in adult patients with Wilson’s disease. Liver Transpl 2007;13(1):55-61.PubMedCrossRef
19.
go back to reference Vaquero J, Butterworth RF. Mild hypothermia for the treatment of acute liver failure – what are we waiting for? Nat Clin Pract Gastroenterol Hepatol 2007;4(10):528-9.PubMedCrossRef Vaquero J, Butterworth RF. Mild hypothermia for the treatment of acute liver failure – what are we waiting for? Nat Clin Pract Gastroenterol Hepatol 2007;4(10):528-9.PubMedCrossRef
20.
go back to reference Hoek B van, et al. Protocol indicatiestelling en selectie voor levertransplantatie bij volwassenen in Nederland. Herziene versie 2002. www.hepatologie.org. Hoek B van, et al. Protocol indicatiestelling en selectie voor levertransplantatie bij volwassenen in Nederland. Herziene versie 2002. www.​hepatologie.​org.
21.
go back to reference Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008;8(3):667-72.PubMedCrossRef Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008;8(3):667-72.PubMedCrossRef
22.
go back to reference Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson Comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-20.PubMedCrossRef Volk ML, Hernandez JC, Lok AS, Marrero JA. Modified Charlson Comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-20.PubMedCrossRef
23.
go back to reference Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006;82(12):1683-8. Erratum in: Transplantation 2007;83(4):521.CrossRef Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006;82(12):1683-8. Erratum in: Transplantation 2007;83(4):521.CrossRef
25.
go back to reference Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G, Karani J, Champion MP, Heaton N, Mohamed R, Dhawan A. Hepatocyte transplantation followed by auxiliary liver transplantation – a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 2008;8(2):452-7.PubMedCrossRef Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G, Karani J, Champion MP, Heaton N, Mohamed R, Dhawan A. Hepatocyte transplantation followed by auxiliary liver transplantation – a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 2008;8(2):452-7.PubMedCrossRef
26.
go back to reference Hoek B van, Boer J de, Boudjema K, Williams R, Corsmit O, Terpstra OT. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol 1999;30(4):699-705.PubMedCrossRef Hoek B van, Boer J de, Boudjema K, Williams R, Corsmit O, Terpstra OT. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol 1999;30(4):699-705.PubMedCrossRef
27.
go back to reference Ringers J, Baranski AG, Dubbeld J, Sarton E, Veenendaal RA, Schaapherder AF, Linden E van der, Terpstra OT, Hoek B van. A novel technique for auxiliary partial liver transplantation with reno-portal anastomosis and avoidance of the hepatoduodenal ligament. Am J Transplant 2006;6(11):2802-8.PubMedCrossRef Ringers J, Baranski AG, Dubbeld J, Sarton E, Veenendaal RA, Schaapherder AF, Linden E van der, Terpstra OT, Hoek B van. A novel technique for auxiliary partial liver transplantation with reno-portal anastomosis and avoidance of the hepatoduodenal ligament. Am J Transplant 2006;6(11):2802-8.PubMedCrossRef
28.
go back to reference Ringers J, Dubbeld J, Baranski AG, Coenraad M, Sarton E, Schaapherder AF, Hoek B van. Reuse of auxiliary liver grafts in second recipients with chronic liver disease. Am J Transplant 2007;7(11):2615-8.PubMedCrossRef Ringers J, Dubbeld J, Baranski AG, Coenraad M, Sarton E, Schaapherder AF, Hoek B van. Reuse of auxiliary liver grafts in second recipients with chronic liver disease. Am J Transplant 2007;7(11):2615-8.PubMedCrossRef
29.
go back to reference Belghiti J, Sommacale D, Dondéro F, Zinzindohoué F, Sauvanet A, Durand F. Auxiliary liver transplantation for acute liver failure. HPB (Oxford) 2004;6(2):83-7.CrossRef Belghiti J, Sommacale D, Dondéro F, Zinzindohoué F, Sauvanet A, Durand F. Auxiliary liver transplantation for acute liver failure. HPB (Oxford) 2004;6(2):83-7.CrossRef
30.
go back to reference Lodge JP, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, Millson C, Breslin N, Wyatt J, Robinson PJ, Bellamy MC, Snook N, Pollard SG. Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success. Ann Surg 2008;247(2):238-49.PubMedCrossRef Lodge JP, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, Millson C, Breslin N, Wyatt J, Robinson PJ, Bellamy MC, Snook N, Pollard SG. Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success. Ann Surg 2008;247(2):238-49.PubMedCrossRef
31.
go back to reference Ghobrial RM, Yersiz H, Farmer DG, Amersi F, Goss J, Chen P, Dawson S, Lerner S, Nissen N, Imagawa D, Colquhoun S, Arnout W, McDiarmid SV, Busuttil RW. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000;232(3):312-23.PubMedCentralPubMedCrossRef Ghobrial RM, Yersiz H, Farmer DG, Amersi F, Goss J, Chen P, Dawson S, Lerner S, Nissen N, Imagawa D, Colquhoun S, Arnout W, McDiarmid SV, Busuttil RW. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000;232(3):312-23.PubMedCentralPubMedCrossRef
32.
go back to reference Broering D, Schulte Am Esch J, Fischer L, Rogiers X. Split liver transplantation. HPB (Oxford) 2004;6(2):76-82.CrossRef Broering D, Schulte Am Esch J, Fischer L, Rogiers X. Split liver transplantation. HPB (Oxford) 2004;6(2):76-82.CrossRef
33.
go back to reference Wilczek HE, Larsson M, Yamamoto S, Ericzon BG. Domino liver transplantation. J Hepatobiliary Pancreat Surg 2008;15(2):139-48.PubMedCrossRef Wilczek HE, Larsson M, Yamamoto S, Ericzon BG. Domino liver transplantation. J Hepatobiliary Pancreat Surg 2008;15(2):139-48.PubMedCrossRef
34.
go back to reference Tamura S, Sugawara Y, Kokudo N. Donor evaluation and hepatectomy for living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2008;15(2):79-91.PubMedCrossRef Tamura S, Sugawara Y, Kokudo N. Donor evaluation and hepatectomy for living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2008;15(2):79-91.PubMedCrossRef
35.
go back to reference Soejima Y, Taketomi A, Ikegami T, Yoshizumi T, Uchiyama H, Yamashita Y, Meguro M, Harada N, Shimada M, Maehara Y. Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems? Am J Transplant 2008;8(4):887-92.PubMedCrossRef Soejima Y, Taketomi A, Ikegami T, Yoshizumi T, Uchiyama H, Yamashita Y, Meguro M, Harada N, Shimada M, Maehara Y. Living donor liver transplantation using dual grafts from two donors: a feasible option to overcome small-for-size graft problems? Am J Transplant 2008;8(4):887-92.PubMedCrossRef
36.
go back to reference Sevmis S, Karakayali H, Karakayali F, Savas NA, Akkoc H, Haberal M. Postsurgical complications in living-related liver donors. Transplant Proc 2008;40(1):245-7.PubMedCrossRef Sevmis S, Karakayali H, Karakayali F, Savas NA, Akkoc H, Haberal M. Postsurgical complications in living-related liver donors. Transplant Proc 2008;40(1):245-7.PubMedCrossRef
37.
go back to reference Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE, A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007;133(6):1806-13.PubMedCentralPubMedCrossRef Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE, A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007;133(6):1806-13.PubMedCentralPubMedCrossRef
38.
go back to reference McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007;246(6):940-6; discussion 946-8. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007;246(6):940-6; discussion 946-8.
39.
go back to reference Pertejo MA, Torres JG, Gillem PG, Jiménez JC, Rodríguez FS, Argente GR, Aleixandre IS. Initial poor function in the age of old donors: prognostic factors. Transplant Proc 2007;39(7):2109-11.PubMedCrossRef Pertejo MA, Torres JG, Gillem PG, Jiménez JC, Rodríguez FS, Argente GR, Aleixandre IS. Initial poor function in the age of old donors: prognostic factors. Transplant Proc 2007;39(7):2109-11.PubMedCrossRef
40.
go back to reference Hoekstra H, Tian Y, Jochum W, Stieger B, Graf R, Porte RJ, Clavien PA. Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation 2008;85(8):1159-66.PubMedCrossRef Hoekstra H, Tian Y, Jochum W, Stieger B, Graf R, Porte RJ, Clavien PA. Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation 2008;85(8):1159-66.PubMedCrossRef
41.
go back to reference Boyvat F, Aytekin C, Harman A, Sevmiş S, Karakayali H, Haberal M. Endovascular stent placement in patients with hepatic artery stenoses or thromboses after liver transplant. Transplant Proc 2008;40(1):22-6.PubMedCrossRef Boyvat F, Aytekin C, Harman A, Sevmiş S, Karakayali H, Haberal M. Endovascular stent placement in patients with hepatic artery stenoses or thromboses after liver transplant. Transplant Proc 2008;40(1):22-6.PubMedCrossRef
42.
go back to reference Eksteen B, Neuberger JM. Mechanisms of disease: the evolving understanding of liver allograft rejection. Nat Clin Pract Gastroenterol Hepatol 2008;5(4):209-19.PubMedCrossRef Eksteen B, Neuberger JM. Mechanisms of disease: the evolving understanding of liver allograft rejection. Nat Clin Pract Gastroenterol Hepatol 2008;5(4):209-19.PubMedCrossRef
43.
go back to reference Piselli P, Zanfi C, Corazza V, Ferretti S, Scuderi M, Arana MG, Secchia SB, Lauro A, Dazzi A, Pinna A, Ettorre GM, Vennarecci G, Santoro R, Ferretti G, Gusman N, Berloco PB, Grossi P, Angeletti C, Bellelli S, Costa AN, Ippolito G, Girardi E, Serraino D. Incidence and timing of infections after liver transplant in Italy. Transplant Proc 2007;39(6):1950-2. Erratum in: Transplant Proc 2007;39(9):2930. Piselli P, Zanfi C, Corazza V, Ferretti S, Scuderi M, Arana MG, Secchia SB, Lauro A, Dazzi A, Pinna A, Ettorre GM, Vennarecci G, Santoro R, Ferretti G, Gusman N, Berloco PB, Grossi P, Angeletti C, Bellelli S, Costa AN, Ippolito G, Girardi E, Serraino D. Incidence and timing of infections after liver transplant in Italy. Transplant Proc 2007;39(6):1950-2. Erratum in: Transplant Proc 2007;39(9):2930.
44.
go back to reference Bedini A, Codeluppi M, Cocchi S, Guaraldi G, Di Benedetto F, Venturelli C, Masetti M, Prati F, Mussini C, Borghi V, Girardis M, Gerunda GE, Rumpianesi F, Esposito R. Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc 2007;39(6):1947-9.PubMedCrossRef Bedini A, Codeluppi M, Cocchi S, Guaraldi G, Di Benedetto F, Venturelli C, Masetti M, Prati F, Mussini C, Borghi V, Girardis M, Gerunda GE, Rumpianesi F, Esposito R. Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc 2007;39(6):1947-9.PubMedCrossRef
45.
go back to reference Bouwman LH, Roos A, Terpstra OT, Knijff P de, Hoek B van, Verspaget HW, Berger SP, Daha MR, Frölich M, Slik AR van der, Doxiadis II, Roep BO, Schaapherder AF. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005;129(2):408-14.PubMedCrossRef Bouwman LH, Roos A, Terpstra OT, Knijff P de, Hoek B van, Verspaget HW, Berger SP, Daha MR, Frölich M, Slik AR van der, Doxiadis II, Roep BO, Schaapherder AF. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005;129(2):408-14.PubMedCrossRef
46.
go back to reference Mark W, Graziadei I, Bargehr D, Vogel W, Boesmueller C, Tabarelli W, Pomarolli A, Ladumer R, Steurer W, Koenigsrainer A, Margreiter R, Bonatti H. Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients. Transplant Proc 2005;37(2):1224-6.PubMedCrossRef Mark W, Graziadei I, Bargehr D, Vogel W, Boesmueller C, Tabarelli W, Pomarolli A, Ladumer R, Steurer W, Koenigsrainer A, Margreiter R, Bonatti H. Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients. Transplant Proc 2005;37(2):1224-6.PubMedCrossRef
47.
go back to reference Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl 2005;11(6):656-62.PubMedCrossRef Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl 2005;11(6):656-62.PubMedCrossRef
48.
go back to reference Shah T, Lai WK, Mutimer D. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors. Transpl Infect Dis 2005;7(2):57-62.PubMedCrossRef Shah T, Lai WK, Mutimer D. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors. Transpl Infect Dis 2005;7(2):57-62.PubMedCrossRef
49.
go back to reference Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Posttransplantation lymphoproliferative disorder – the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Liver Transpl 2007;13(6):904-12.PubMedCrossRef Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Posttransplantation lymphoproliferative disorder – the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Liver Transpl 2007;13(6):904-12.PubMedCrossRef
50.
go back to reference Holt AP, Thorburn D, Mirza D, Gunson B, Wong T, Haydon G. A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation. Transplantation 2007;84(7):857-63.PubMedCrossRef Holt AP, Thorburn D, Mirza D, Gunson B, Wong T, Haydon G. A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation. Transplantation 2007;84(7):857-63.PubMedCrossRef
51.
go back to reference Verdonk RC, Buis CI, Jagt EJ van der, Gouw AS, Limburg AJ, Slooff MJ, Kleibeuker JH, Porte RJ, Haagsma EB. Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl 2007;13(5):725-32.PubMedCrossRef Verdonk RC, Buis CI, Jagt EJ van der, Gouw AS, Limburg AJ, Slooff MJ, Kleibeuker JH, Porte RJ, Haagsma EB. Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl 2007;13(5):725-32.PubMedCrossRef
52.
go back to reference Dubbeld J. Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, Baranski AG, Kazemier G, Coenraad MJ, Berg AP van den, Hoek B van. Similar graft and patient survival in liver transplantation with brain death and controlled cardiac death donors with restrictive acceptance criteria. Aangeboden. Dubbeld J. Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, Baranski AG, Kazemier G, Coenraad MJ, Berg AP van den, Hoek B van. Similar graft and patient survival in liver transplantation with brain death and controlled cardiac death donors with restrictive acceptance criteria. Aangeboden.
53.
go back to reference Pfitzmann R, Nüssler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P. Long-term results after liver transplantation. Transpl Int 2008;21(3):234-46.PubMedCrossRef Pfitzmann R, Nüssler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P. Long-term results after liver transplantation. Transpl Int 2008;21(3):234-46.PubMedCrossRef
54.
go back to reference Bismuth H, Houssin D. Reduced size orthotopic liver graft in hepatic transplantation in children. Surgery 1984;95:367-70.PubMed Bismuth H, Houssin D. Reduced size orthotopic liver graft in hepatic transplantation in children. Surgery 1984;95:367-70.PubMed
55.
go back to reference Porte RJ. Split-levertransplantatie. In: Duin F van, Haase B, Hoitsma A, Porte RJ, redactie. Orgaan- en weefseldonatie en transplantatie. Nederlandse Transplantatie Vereniging, 2007. Porte RJ. Split-levertransplantatie. In: Duin F van, Haase B, Hoitsma A, Porte RJ, redactie. Orgaan- en weefseldonatie en transplantatie. Nederlandse Transplantatie Vereniging, 2007.
56.
go back to reference Pichelmayr R, Ringe B, Gubernatis G, et al. Transplantation einer Spenderleber auch bei zwei Empfänger (Splittingtranspantation): eine neue Methode in der Weiterentwicklung der Lebersegementtransplantation. Langenbecks Arch Chir 1988;373:127-30.CrossRef Pichelmayr R, Ringe B, Gubernatis G, et al. Transplantation einer Spenderleber auch bei zwei Empfänger (Splittingtranspantation): eine neue Methode in der Weiterentwicklung der Lebersegementtransplantation. Langenbecks Arch Chir 1988;373:127-30.CrossRef
57.
go back to reference Slooff MJH, Kazemier G. Levertransplantatie met een levende donor. Ned Tijdschr Geneeskd 2004;148:2257-9.PubMed Slooff MJH, Kazemier G. Levertransplantatie met een levende donor. Ned Tijdschr Geneeskd 2004;148:2257-9.PubMed
58.
go back to reference Scheenstra R, Gerver WJ, Odink RJ, Soest H van, Peeters PMJG, Verkade HJ, Sauer PJJ. Growth and final height after liver transplantation during childhood. J Pediatr Gastroenterol Nutr 2008;47:165-71.PubMedCrossRef Scheenstra R, Gerver WJ, Odink RJ, Soest H van, Peeters PMJG, Verkade HJ, Sauer PJJ. Growth and final height after liver transplantation during childhood. J Pediatr Gastroenterol Nutr 2008;47:165-71.PubMedCrossRef
59.
go back to reference Scheenstra R, Verschuuren EAM, Haan A de, Slooff MJH, The TH, Bijleveld CMA, Verkade HJ. The value of prospective monitoring of EBV DNA in blood samples of pediatric liver transplant recipients. Transpl Infect Dis 2004;6:15-22.PubMedCrossRef Scheenstra R, Verschuuren EAM, Haan A de, Slooff MJH, The TH, Bijleveld CMA, Verkade HJ. The value of prospective monitoring of EBV DNA in blood samples of pediatric liver transplant recipients. Transpl Infect Dis 2004;6:15-22.PubMedCrossRef
Metagegevens
Titel
22 Levertransplantatie
Auteurs
Dr. B. van Hoek
Prof.dr. H.J. Verkade
Prof.dr. R.J. Porte
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-7437-3_22